Usa covid-19 vaccine Usa

AstraZeneca study finds small clot risk after 1st COVID-19 shot, none after 2nd

Reading now: 627
www.fox29.com

published July 28 in the medical journal The Lancet, comes after reports of the vaccine being possibly linked to rare blood clotting — which has caused some countries to limit its use in younger people.

The two-dose vaccine has not yet been approved for use in the United States but has received authorization from more than 170 countries.The study found that rates of the rare clotting disorder, known as thrombosis with thrombocytopenia syndrome (TTS), after the first dose were about 8.1 per million vaccines.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA